Organogenesis Holdings Inc.

ORGO ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017 FY2016 FY2015
Assets
Cash & Equivalents $2.4M $1.9M $1.2M
Accounts Receivable $28.1M — —
Inventory $14.3M — —
Total Current Assets $49.7M $1.4M $126.1K
Property, Plant & Equipment $42.1M — —
Goodwill $25.5M — —
Intangible Assets (Excl. Goodwill) $29.8M — —
Total Assets $148.7M $311.4M $416.3K
Liabilities
Accounts Payable $19.1M — —
Total Current Liabilities $52.0M $478.4K $416.4K
Long-Term Debt $52.1M — —
Total Liabilities $157.3M $11.3M $416.4K
Stockholders' Equity
Retained Earnings $-65.4M $-233.9K $-25.2K
Total Stockholders' Equity $-15.3M $-16.0M $3.5M
← Newer Page 2 of 2 Older →